Shockwave Therapy (and all variable titles and abbreviations) is intended for improvement of patient’s health. All content found on the swsna.org Website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.
Results and patient experience may vary.
As with any medical procedure, ask your doctor if the procedure is right for you. Patient names have been changed for their privacy.
These products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications.
US FDA clearances:
Although ESWT has not been definitively shown to be effective, it has been approved by the US Food and Drug Administration (FDA) for the treatment of plantar fasciitis and tennis elbow. ESWT is noninvasive, has few adverse side effects, and is associated with a good recovery time in patients with chronic plantar fasciitis; however, it is not covered by most insurance plans.